Metastatic Urethral Urothelial Carcinoma Active Not Recruiting Phase 3 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0110111 (Metastatic Urethral Urothelial Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00942331Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerTreatment